… were symptomatic recurrent venous thromboembolism, major … low-molecular-weight
heparin is at least equivalent to unfractionated heparin in patients with venous thromboembolism…

… venous thromboembolism or major bleeding were observed. … than UFH in preventing
recurrent venous thromboembolism, … acute thromboembolism with low molecular weight heparin (…

… -molecular-weight heparins in large trials. … of low-dose heparin with that of low-molecular-weight
heparin in patients with major trauma, using deep-vein thrombosis demonstrated by …

… and bleeding in the other 3 patients in the unfractionated heparin group, and no follow-…
low-molecular-weight heparin group (not known to have had recurrent venous thromboembolism …

… intravenous unfractionated heparin for preventing recurrent venous thromboembolism in …
deep vein thrombosis. Our findings extend the use of low-molecular-weight heparin without …

… Moderate‐quality evidence showed that the use of low molecular weight heparin (LMWH)
in outpatients reduced the number of venous thromboembolic events when a plaster cast or …

… low-molecularweight heparin with unfractionated heparin, we … recurrent venous
thromboembolism with unfractionated heparin … venous thromboembolism associated with the use …

… acute deep-vein thrombosis to one of three treatment regimens: intravenous administration
of unfractionated heparin; subcutaneous administration of a low-molecular-weight heparin, …

… We conclude that low molecular weight heparin (… venous thromboembolism compared with
heparin. There is a trend in risk reduction for bleeding in favor of low molecular weight heparin…

… Background: The management of venous thromboembolism (VTE) requires an initial treatment
with unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH), followed by …